Premium
P2‐364: Surrogate decision and advance directives authorization to treatment of curable and incurable concomitant disease in dementia: a Brazilian perspective.
Author(s) -
Neto Ylmar Correa,
Rego Guilhermina,
Nunes Rui
Publication year - 2011
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2011.05.1240
Subject(s) - concomitant , medicine , disease , dementia , autonomy , authorization , family medicine , physical therapy , intensive care medicine , surgery , computer security , computer science , political science , law
rogate decision (p 0.035, 0.011 and 0.007) and advance directives (p 0.025, 0.018 and 0.002). This tendency did not changed authorization or refuse rates, except to orotracheal intubation (p 0.0302 and 0.0456 for caregivers surrogate decision and 0.0082 and 0.0302 for caregivers advance directives). In the same group a tendency to refuse authorization to orotracheal intubation and tracheostomy were observed when comparing advance directives with surrogate decisions (p 0.013 and 0.049). Conclusions: The daily contact with demented patients changes attitudes concerning feeding and respiratory devices.